High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial by Thiel, Eckhard, Prof, Korfel, Agnieszka, MD, Martus, Peter, Prof, Kanz, Lothar, Prof, Griesinger, Frank, MD, Rauch, Michael, MD, Röth, Alexander, MD, Hertenstein, Bernd, MD, von Toll, Theda, MD, Hundsberger, Thomas, MD, Mergenthaler, Hans-Günther, MD, Leithäuser, Malte, MD, Birnbaum, Tobias, MD, Fischer, Lars, MD, Jahnke, Kristoph, MD, Herrlinger, Ulrich, MD, Plasswilm, Ludwig, MD, Nägele, Thomas, MD, Pietsch, Torsten, Prof, Bamberg, Michael, Prof, Weller, Michael, Prof

Get full text

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study by Crinò, Lucio, Prof, Dansin, Eric, MD, Garrido, Pilar, MD, Griesinger, Frank, Prof, Laskin, Janessa, MD, Pavlakis, Nick, MBBS, Stroiakovski, Daniel, Prof, Thatcher, Nick, Prof, Tsai, Chun-Ming, Prof, Wu, Yi-long, Prof, Zhou, Caicun, Prof

Get full text